Selcuk R. Erdem
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Outcomes of [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide in metastatic castration-resistant prostate cancer: a single-center retrospective study.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 02, 2026
The expression and prognostic significance of immune checkpoint molecules across clear cell, papillary and chromophobe renal cell carcinoma subtypes.
Journal: International urology and nephrology
Published: June 25, 2026
The effect of toll like receptors in prognosis in patients undergoing radical cystectomy for bladder cancer.
Journal: Molecular biology reports
Published: May 26, 2026
ZEB1-AS1 and miR-200b-3p Expression in Non-Muscle-Invasive Bladder Cancer: Pathological Correlates.
Journal: Journal of clinical medicine
Published: May 01, 2026
What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group.
Journal: World journal of urology
Published: April 24, 2026
Does WHO/ISUP grade IV histology provide prognostic insight in chromophobe renal cell carcinoma?
Journal: International urology and nephrology
Published: April 21, 2026
Expression of lncRNA-ATB and miR-200c in patients with bladder cancer: a pilot study.
Journal: Laboratory medicine
Published: April 09, 2026
Enucleation versus enucleoresection in robotic partial nephrectomy: Real-world data from the multicenter YAU kidney cancer database.
Journal: Surgical oncology
Published: February 14, 2026
YAU-RCC spotlight: dual VEGF/EGFR blockade shows promise for reshaping the treatment of papillary RCC in hereditary leiomyomatosis and renal cell cancer syndrome.
Journal: Minerva urology and nephrology
Published: October 23, 2025
Genetic Testing and Counselling for Hereditary Renal Carcinoma: What Do Clinicians Need to Know?
Journal: European urology open science
Published: October 16, 2025
Genome-wide transcriptional profiling identifies molecular markers associated with early carcinogenesis in high-grade bladder cancer.
Journal: Scientific reports
Published: October 11, 2025
Last Updated: 09/26/2026